Nadine Rouphael

25.5k total citations · 1 hit paper
122 papers, 3.3k citations indexed

About

Nadine Rouphael is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Nadine Rouphael has authored 122 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Epidemiology, 47 papers in Infectious Diseases and 25 papers in Immunology. Recurrent topics in Nadine Rouphael's work include Influenza Virus Research Studies (24 papers), SARS-CoV-2 and COVID-19 Research (19 papers) and Respiratory viral infections research (16 papers). Nadine Rouphael is often cited by papers focused on Influenza Virus Research Studies (24 papers), SARS-CoV-2 and COVID-19 Research (19 papers) and Respiratory viral infections research (16 papers). Nadine Rouphael collaborates with scholars based in United States, Mexico and China. Nadine Rouphael's co-authors include David S. Stephens, Mark J. Mulligan, Naasha J Talati, Carolyn Gould, Kelly Cunningham, Camille P. Vaughan, Roger K. Moreira, Bali Pulendran, Rafi Ahmed and Evan J. Anderson and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Immunity.

In The Last Decade

Nadine Rouphael

113 papers receiving 3.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular signatures of antibody responses derived from a systems biology study of five human vaccines

2013 462 citations Nadine Rouphael, Mark J. Mulligan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nadine Rouphael United States	27	1.5k	1.4k	949	638	414	122	3.3k
Donna M. Ambrosino United States	26	1.8k 1.3×	2.5k 1.9×	776 0.8×	413 0.6×	185 0.4×	46	4.3k
Johannes G. Liese Germany	35	2.5k 1.7×	811 0.6×	947 1.0×	335 0.5×	109 0.3×	133	4.3k
Richard L. Hodinka United States	36	1.8k 1.2×	1.5k 1.1×	321 0.3×	450 0.7×	113 0.3×	108	3.7k
Pier‐Angelo Tovo Italy	42	1.9k 1.3×	1.8k 1.3×	1.1k 1.2×	412 0.6×	277 0.7×	190	5.0k
Henry M. Feder United States	31	768 0.5×	1.5k 1.1×	406 0.4×	769 1.2×	257 0.6×	98	3.5k
Joseph D. Schwartzman United States	41	2.3k 1.5×	1.1k 0.8×	919 1.0×	827 1.3×	80 0.2×	95	5.4k
Nico G. Hartwig Netherlands	29	1.0k 0.7×	1.1k 0.8×	461 0.5×	187 0.3×	112 0.3×	69	2.5k
Malcolm Guiver United Kingdom	34	2.6k 1.8×	1.0k 0.8×	336 0.4×	467 0.7×	127 0.3×	88	3.9k
Juan C. Salazar United States	31	399 0.3×	691 0.5×	774 0.8×	514 0.8×	106 0.3×	65	2.6k
Guy A. M. Berbers Netherlands	44	4.2k 2.9×	1.3k 0.9×	1.0k 1.1×	865 1.4×	228 0.6×	204	6.6k

Countries citing papers authored by Nadine Rouphael

Since Specialization

Citations

This map shows the geographic impact of Nadine Rouphael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadine Rouphael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadine Rouphael more than expected).

Fields of papers citing papers by Nadine Rouphael

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadine Rouphael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadine Rouphael. The network helps show where Nadine Rouphael may publish in the future.

Co-authorship network of co-authors of Nadine Rouphael

This figure shows the co-authorship network connecting the top 25 collaborators of Nadine Rouphael. A scholar is included among the top collaborators of Nadine Rouphael based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadine Rouphael. Nadine Rouphael is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pauly, Matthew D., David VanInsberghe, Shamika Danzy, et al.. (2026). Within-host adaptive evolution is limited by genetic drift in experimental human influenza A virus infections. bioRxiv (Cold Spring Harbor Laboratory). 1 indexed citations

King, Laura, Kristin L. Andrejko, Miwako Kobayashi, et al.. (2025). Pneumococcal Serotype Distribution and Coverage of Existing and Pipeline Pneumococcal Vaccines. The Journal of Infectious Diseases. 232(4). e609–e620.

Sherman, Amy C, Glenda Gray, Bin Cao, et al.. (2025). Acute SARS-CoV-2 infection. Nature Reviews Disease Primers. 11(1). 75–75.

Graciaa, Daniel S., et al.. (2024). Systems Vaccinology: Navigating the Future of Personalized Immunity and Next-Generation Vaccines. The Journal of Infectious Diseases. 230(6). 1305–1308. 1 indexed citations

Gromer, Daniel, et al.. (2024). The Relationship between Immunogenicity and Reactogenicity of Seasonal Influenza Vaccine Using Different Delivery Methods. Vaccines. 12(7). 809–809.

Liu, Pengbo, Yuke Wang, Lana Khalil, et al.. (2024). Longitudinal fecal shedding of SARS-CoV-2, pepper mild mottle virus, and human mitochondrial DNA in COVID-19 patients. Frontiers in Medicine. 11. 1417967–1417967. 1 indexed citations

Graciaa, Daniel S., Stephen R. Walsh, & Nadine Rouphael. (2024). Human Immunodeficiency Virus Vaccine. Infectious Disease Clinics of North America. 38(3). 475–485. 2 indexed citations

Kao, Carol, Christina A. Rostad, L. Nolan, et al.. (2024). A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults. The Journal of Infectious Diseases. 230(5). 1093–1101. 9 indexed citations

Rouphael, Nadine & Mary T. Bausch-Jurken. (2023). COVID-19 Vaccination Among Patients Receiving Maintenance Renal Replacement Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future. The Journal of Infectious Diseases. 228(Supplement_1). S46–S54. 6 indexed citations

10.

Samaha, Hady, et al.. (2023). Efficacy and Durability of Immune Response after Receipt of HPV Vaccines in People Living with HIV. Vaccines. 11(6). 1067–1067. 4 indexed citations

11.

Goll, Johannes B., Steven E. Bosinger, Hasse Walum, et al.. (2023). The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies. Frontiers in Immunology. 13. 1093242–1093242. 2 indexed citations

12.

Ortiz, Justin R., David I. Bernstein, Daniel F. Hoft, et al.. (2023). A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults. The Journal of Infectious Diseases. 228(3). 287–298. 6 indexed citations

13.

Jackson, Lisa A., Jack T. Stapleton, Emmanuel B. Walter, et al.. (2023). Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults. Vaccine. 42(2). 295–309. 2 indexed citations

14.

Thompson, Elizabeth A., Jennifer L. Alejo, Hady Samaha, et al.. (2023). Heterologous versus homologous boosting elicits qualitatively distinct, BA.5–cross-reactive T cells in transplant recipients. JCI Insight. 8(10). 8 indexed citations

15.

Rosenberg‐Hasson, Yael, Tyson H. Holmes, Joann Diray‐Arce, et al.. (2023). Relationship of Heterologous Virus Responses and Outcomes in Hospitalized COVID-19 Patients. The Journal of Immunology. 211(8). 1224–1231. 1 indexed citations

16.

Wiley, Zanthia, Lana Khalil, Matthew Lee, et al.. (2022). A Framework for Inspiring COVID-19 Vaccine Confidence in African American and Latino Communities. Vaccines. 10(8). 1319–1319. 12 indexed citations

17.

Shantha, Jessica G., Sara C. Auld, Kenneth W. Price, et al.. (2021). COVID-19 associated retinopathy. Investigative Ophthalmology & Visual Science. 62(8). 1993–1993. 1 indexed citations

18.

Carr, Michael, John A. Lewis, Krisha Desai, et al.. (2021). Immune thrombocytopenia in 2 healthy young women after the Pfizer‐BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination. SHILAP Revista de lepidopterología. 2(5). e12531–e12531. 5 indexed citations

19.

Drobeniuc, Ana, Jessica Traenkner, Paulina A. Rebolledo, Varduhi Ghazaryan, & Nadine Rouphael. (2021). Staphylococcus simulans: A rare uropathogen. IDCases. 25. e01202–e01202. 7 indexed citations

20.

Chang, Yie‐Hwa, Duc M. Duong, Johannes B. Goll, et al.. (2020). Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine. Vaccines. 8(3). 413–413. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact